Keywords: ایمونوتراپی; Nasopharyngeal carcinoma; Recurrent; Metastatic; Chemotherapy; Targeted therapy; Immunotherapy; Checkpoint inhibitors;
مقالات ISI ایمونوتراپی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمونوتراپی; Infective endocarditis; Corticosteroids; Enterococcus faecalis; Immunotherapy;
Keywords: ایمونوتراپی; Tumor infiltrating lymphocytes; Gastrointestinal tumors; Microsatellite instability; Prognosis; Immunotherapy;
Keywords: ایمونوتراپی; Allergen challenge; allergen peptides; allergy; allergic rhinoconjunctivitis; allergic rhinitis; environmental exposure unit; epitope; grass; immunotherapy; synthetic peptide immunoregulatory epitope; AE; Adverse events; AIT; Allergen immunotherapy; ARC;
Keywords: ایمونوتراپی; Immunotherapy; Immune-checkpoint blockade; Tumor immunology; Tumor microenvironment; Personalized medicine;
Keywords: ایمونوتراپی; Metronomic chemotherapy; Immunotherapy; Cancer therapy;
Keywords: ایمونوتراپی; Quantum dots; Immunoassay; Immunosensor; Immunofluorescent imaging; Immunotherapy;
Keywords: ایمونوتراپی; Metronomic chemotherapy; Metastasis; Animal models; Antiangiogenesis; Vessel co-option; Immunotherapy;
Keywords: ایمونوتراپی; Dendritic cell targeting; Immunotherapy; Tumor cell lysates; Nano-vaccine; Chitosan;
Keywords: ایمونوتراپی; Amyloidosis; Anti-Aβ antibody; APP/PS1 mouse; Immunotherapy; Liposome;
Keywords: ایمونوتراپی; Antibody-cytokine fusion proteins; Cancer; Monoclonal antibody; Immunotherapy;
Keywords: ایمونوتراپی; Angiogenesis; Gastric cancer; Esophageal cancer; Immunotherapy; Checkpoint inhibitor;
Keywords: ایمونوتراپی; Erlotinib; Vascular normalization; Tumor microenvironment; Nanomedicine; Immunotherapy;
Keywords: ایمونوتراپی; Fluorescence; Nanodiamonds; Immunotherapy; Natural killer cells; Monocytes; Ab; antibody; APC; allphycocyanin; ELISA; enzyme-linked immunosorbent assay; FND(s); fluorescent nanodiamond(s); FS; forward laser light scatter; HAB; human AB serum; HLA; human l
Keywords: ایمونوتراپی; Prostate cancer; Metastatic; Castration-resistant; Immunotherapy; Immune checkpoint inhibitor; Vaccines; Oncolytic viruses;
Keywords: ایمونوتراپی; Cationic co-polymers; Glatiramoids; Immunotherapy; Cathelicidins;
Keywords: ایمونوتراپی; immunotherapy; immune checkpoint inhibitors; interprofessional collaboration;
Keywords: ایمونوتراپی; Inflammatory breast cancer; IBC; Comparative oncology; Dog; Canine inflammatory mammary carcinoma; CIMC; Immunotherapy; Preclinical models;
Keywords: ایمونوتراپی; Targeted therapy; Immunotherapy; Sinonasal malignancy; Head and neck squamous cell carcinoma; Sinonasal tumors; Cell-mediated immunity; Head and neck melanoma; Mucosal melanoma;
Keywords: ایمونوتراپی; Stereotactic radiotherapy; Targeted therapy; Concurrent; Immunotherapy; Toxicity;
Keywords: ایمونوتراپی; Renal cell cancer; Targeted therapy; Angiogenesis; Monoclonal antibody; Tyrosine-kinase inhibitor; mTOR inhibitor; Immunotherapy;
Keywords: ایمونوتراپی; Immune checkpoint inhibitors; Immunotherapy; Programmed cell death 1; Programmed cell death receptor ligand 1; Cytotoxic T lymphocyte-associated protein 4; Urothelial cell cancer; Renal cell cancer; Prostate cancer; Urological cancer;
Keywords: ایمونوتراپی; Distal cholangiocarcinoma; Intrahepatic cholangiocarcinoma; Immunotherapy; Perihilar cholangiocarcinoma; Targeted therapy;
Keywords: ایمونوتراپی; TME; tumour microenvironment; PD-1; programmed cell death 1; PD-L1; programmed death ligand 1; PD-L2; programmed death ligand 2; PTMs; post-translational histone modifications; DNMTi; DNA methyltransferase inhibitor; HDACi; histone deacetylase inhibitor;
Keywords: ایمونوتراپی; Immunotherapy; Kidney cancer; Therapeutic; Unclassified renal cancer; Undifferentiated;
Keywords: ایمونوتراپی; PLGA-microparticles; Drug delivery; Ag-specific; Immunotherapy; EAE; Multiple sclerosis;
Keywords: ایمونوتراپی; Sublingual immunotherapy; Allergic rhinitis; Allergic asthma; Asthma; Atopic dermatitis; Food allergy; Allergy; Immunotherapy;
Keywords: ایمونوتراپی; Immune checkpoint; Immunotherapy; Programmed death-1; Cytotoxic T lymphocyte associated protein â4; Pembrolizumab; Nivolumab;
Keywords: ایمونوتراپی; Chemotherapy; Extranodal lymphoma; Immunotherapy; Lumpectomy; Neoplasms of the breast;
Keywords: ایمونوتراپی; Immunotherapy; mechanisms; allergic rhinitis; allergic asthma; long-term tolerance; T cells; B cells; type 2 innate lymphoid cells; IgE-FAB; biomarkers; Breg; Regulatory B; C1Q; Component 1Q; CRTH2; Chemoattractant receptor-homologous molecule expressed
Keywords: ایمونوتراپی; Dendritic cell; Tolerance; Allograft rejection; Autoimmunity; Regulatory T cell; Immunotherapy;
Keywords: ایمونوتراپی; DNA mismatch repair; DNA polymerase epsilon; Microsatellite instability; Colorectal cancer; Endometrial cancer; Neoantigen; Immune signature; Immunotherapy; Immune checkpoint inhibitor;
Keywords: ایمونوتراپی; Tumour-infiltrating lymphocytes; breast cancer; biomarkers; prognosis; immunotherapy; checkpoint blockade;
Keywords: ایمونوتراپی; Head and neck cancer; Squamous cell carcinoma; Immunotherapy; Checkpoint receptors;
Keywords: ایمونوتراپی; PD-1; Immunotherapy; High-affinity mutant; Radio-immunotherapy; PD-1 Ig fusion protein;
Keywords: ایمونوتراپی; Lung cancer; Elderly; Lung cancer screening; Geriatric assessment; Surgical resection; Stereotactic body radiation therapy; Targeted therapy; Immunotherapy;
Keywords: ایمونوتراپی; Adenocarcinoma; Squamous cell carcinoma; Gastric; Esophageal; Immunotherapy; Immune checkpoint; PD-1; PD-L1;
Keywords: ایمونوتراپی; endoplasmic reticulum stress; immunogenic cell death; immunotherapy;
Keywords: ایمونوتراپی; AML; Genomic analysis; Immunotherapy; Novel therapies; Risk classification;
Keywords: ایمونوتراپی; Immunotherapy; ovarian cancer;
Keywords: ایمونوتراپی; prostatic neoplasms; immunotherapy; ADT; androgen deprivation therapy; APC; antigen presenting cell; CRPC; castration resistant prostate cancer; GM-CSF; granulocyte-macrophage colony-stimulating factor; mCRPC; metastatic castration resistant prostate canc
Keywords: ایمونوتراپی; Merkel cell carcinoma; Merkel cell polyomavirus; T antigen; Neuroendocrine carcinoma; Immunotherapy;
Keywords: ایمونوتراپی; Treatment beyond progression; Non-small cell lung carcinoma; PD-1 inhibitor; Immunotherapy;
Keywords: ایمونوتراپی; Squamous cell carcinoma of the anus; Anal carcinoma; Chemotherapy; Radiotherapy; Chemoradiation; Combined modality; Immunotherapy; Local recurrence;
Keywords: ایمونوتراپی; Tumor micro-environment; Immunotherapy; Immune checkpoint inhibitors; BRAF inhibitors; MEK inhibitors; Resistance mechanisms; Outcomes; Combination immunotherapy; Targeted therapy;
Keywords: ایمونوتراپی; Mismatch-repair; Microsatellite instability; Colorectal cancer; Lynch; Immunotherapy;
Keywords: ایمونوتراپی; Lung cancer; Chemotherapy; Targeted therapy; Immunotherapy; Brain metastases;
Keywords: ایمونوتراپی; gene sequencing; immunology; immunotherapy; tumor mutations; CTL; cytotoxic T lymphocyte; ELISPOT; enzyme-linked ImmunoSpot; HLA; human leukocyte antigen; MHC; major histocompatibility complex; PD-1; programmed cell death protein 1; pMHC; peptide MHC;
Keywords: ایمونوتراپی; Nanotechnology; Immunotherapy; Tumor microenvironment; Dendritic cells; Vaccination; Adoptive T cell therapy; Checkpoint therapy; Immunosuppression;
Keywords: ایمونوتراپی; Systems biology; Immunotherapy; Cancer genomics; Whole exome sequencing; RNA sequencing; T-cell receptors; Neoantigens; HLA typing; Immuno-predictive score; CTL; Cytotoxic T-lymphocyte; HLA; Human leukocyte antigen; HTS; High-throughput sequencing; IHC; i